FDA maps out plan for trials as coronavirus starts to threaten drug research

FDA maps out plan for trials as coronavirus starts to threaten drug research

Source: 
BioPharma Dive
snippet: 

The Food and Drug Administration on Wednesday issued new guidance on how to run clinical trials during the outbreak of the novel coronavirus.